ES8307718A1 - N-(substituted aminoalkanoyl)heterocyclic compounds - Google Patents

N-(substituted aminoalkanoyl)heterocyclic compounds

Info

Publication number
ES8307718A1
ES8307718A1 ES510498A ES510498A ES8307718A1 ES 8307718 A1 ES8307718 A1 ES 8307718A1 ES 510498 A ES510498 A ES 510498A ES 510498 A ES510498 A ES 510498A ES 8307718 A1 ES8307718 A1 ES 8307718A1
Authority
ES
Spain
Prior art keywords
lower alkyl
alkylamino
mercapto
inclusive
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES510498A
Other languages
Spanish (es)
Other versions
ES510498A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
USV Pharmaceutical Corp
Original Assignee
USV Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by USV Pharmaceutical Corp filed Critical USV Pharmaceutical Corp
Publication of ES8307718A1 publication Critical patent/ES8307718A1/en
Publication of ES510498A0 publication Critical patent/ES510498A0/en
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Compounds of the formula < IMAGE > wherein R1 and R2 are hydrogen, lower alkyl or phenyl lower alkyl, R2, R3, R4, R5 and R6 are independently hydrogen, lower alkyl, lower alkenyl, lower alkynyl, aryl, fused aryl-cycloalkyl, aralkyl, cycloalkyl, heterocyclic, substituted lower alkyl, lower alkenyl, and lower alkynyl groups wherein the substituent is hydroxy, alkoxy, halo, amino, alkylamino, mercapto and alkylmercapto groups, and substituted cycloalkyl, aryl and heterocyclic groups in which the substituent is alkyl, hydroxy, alkoxy, hydroxyalkyl, halo, mercapto, alkylmercapto, mercaptoalkyl, haloalkyl, amino, alkylamino, aminoalkyl, nitro, methylenedioxy, and trifluoromethyl each R8 is lower alkyl, lower alkenyl, lower alkynyl, nitro, amino, alkylamino, dialkylamino, hydroxy, alkoxy, mercapto, alkylmercapto, hydroxyalkyl, mercaptoalkyl, halogen, haloalkyl, aminoalkyl, alkylaminoalkyl, dialkylaminoalky, sulfonamido, methylenedioxy, or trifluoromethyl, m is an integer from 0 to 2 inclusive m' is an integer from 1 to 3 inclusive, provided that when m is 0, m' is 2 or 3 and, when m is other than 0, m' is 1 or 2 n is an integer from 0 to 4 inclusive, and salts thereof, especially pharmaceutically acceptable salts with an acid or a base.
ES510498A 1981-03-19 1982-03-17 "PROCEDURE TO PREPARE AMIDOAMINOACIDOS AND SIMILAR". Granted ES510498A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24540781A 1981-03-19 1981-03-19

Publications (2)

Publication Number Publication Date
ES8307718A1 true ES8307718A1 (en) 1983-08-01
ES510498A0 ES510498A0 (en) 1983-08-01

Family

ID=22926526

Family Applications (3)

Application Number Title Priority Date Filing Date
ES510498A Granted ES510498A0 (en) 1981-03-19 1982-03-17 "PROCEDURE TO PREPARE AMIDOAMINOACIDOS AND SIMILAR".
ES521031A Granted ES521031A0 (en) 1981-03-19 1983-03-16 PROCEDURES FOR OBTAINING AMIDOAMINOACIDES AND THE LIKE.
ES521030A Granted ES521030A0 (en) 1981-03-19 1983-03-16 METHOD OF PREPARING AMINO AMINO ACIDS AND ANALOGS.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES521031A Granted ES521031A0 (en) 1981-03-19 1983-03-16 PROCEDURES FOR OBTAINING AMIDOAMINOACIDES AND THE LIKE.
ES521030A Granted ES521030A0 (en) 1981-03-19 1983-03-16 METHOD OF PREPARING AMINO AMINO ACIDS AND ANALOGS.

Country Status (21)

Country Link
JP (1) JPS57165355A (en)
KR (1) KR890001146B1 (en)
AU (1) AU558451B2 (en)
BE (1) BE892552A (en)
CH (1) CH658455A5 (en)
DE (1) DE3209708A1 (en)
DK (1) DK120982A (en)
ES (3) ES510498A0 (en)
FI (1) FI820974L (en)
FR (1) FR2502149A1 (en)
GB (1) GB2095252B (en)
IE (1) IE53076B1 (en)
IL (1) IL65247A (en)
IN (1) IN156096B (en)
IT (1) IT1150697B (en)
NL (1) NL8201066A (en)
NO (1) NO820903L (en)
NZ (1) NZ200047A (en)
PH (1) PH18657A (en)
SE (1) SE8201654L (en)
ZA (1) ZA821833B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3242599A1 (en) * 1982-11-18 1984-05-24 Dr. Karl Thomae Gmbh, 7950 Biberach NEW BENZAZEPINE DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS
US4410520A (en) * 1981-11-09 1983-10-18 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
US4555502A (en) * 1982-09-30 1985-11-26 Merck & Co., Inc. Aminoacyl-containing dipeptide derivatives useful as antihypertensives
US4410807A (en) * 1982-03-26 1983-10-18 Kay Industries, Inc. Regulating device for polyphase electrical circuits
US4473575A (en) * 1982-07-19 1984-09-25 Ciba-Geigy Corporation 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids
US4520025A (en) * 1982-07-21 1985-05-28 William H. Rorer, Inc. Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
DE3302125A1 (en) * 1983-01-22 1984-07-26 Boehringer Ingelheim KG, 6507 Ingelheim AMINO ACID DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF
DK156484A (en) * 1983-03-16 1984-09-17 Usv Pharma Corp AMINO ACID DERIVATIVES
DE3333454A1 (en) * 1983-09-16 1985-04-11 Hoechst Ag, 6230 Frankfurt METHOD FOR PRODUCING N-ALKYLATED DIPEPTIDES AND THEIR ESTERS
DE3622297A1 (en) * 1986-07-03 1988-01-07 Basf Ag DISAZOTHIOPHENE DYES
US5246943A (en) * 1992-05-19 1993-09-21 Warner-Lambert Company Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties
ES2122941B1 (en) * 1997-05-29 1999-07-01 Esteve Quimica Sa PROCEDURE FOR OBTAINING QUINAPRIL CHLORHYDRATE AND SOLVATES USEFUL FOR THE ISOLATION AND PURIFICATION OF QUINAPRIL CHLORHYDRATE.
SI1333026T1 (en) 2002-01-30 2007-10-31 Servier Lab Process for the preparation of high purity perindopril and intermediates useful in the synthesis
SI1572661T1 (en) 2002-12-16 2007-10-31 Lupin Ltd Crystalline form of quinapril hydrochloride and process for preparing the same
US7521566B2 (en) * 2003-02-28 2009-04-21 Les Laboratoires Servier Process for preparation of perindopril and salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (en) * 1980-10-02 1982-10-08 Science Union & Cie NOVEL SUBSTITUTED IMINO DIACIDES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS AN ENZYME INHIBITOR
DE3177311D1 (en) * 1980-08-30 1994-06-09 Hoechst Ag Amino acid derivatives, processes for their preparation, compositions containing them and their use.
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
GB2086390B (en) * 1980-11-03 1984-06-06 Ciba Geigy Ag 1-carboxy-azaalkanoylindoline-2-carboxylic acids process for their manufacture pharmaceutical preparations containing these compounds and their therapeutic application

Also Published As

Publication number Publication date
DK120982A (en) 1982-09-20
IL65247A (en) 1987-07-31
ES8501363A1 (en) 1984-12-01
IT1150697B (en) 1986-12-17
AU8158482A (en) 1982-09-23
NZ200047A (en) 1985-07-12
GB2095252B (en) 1985-04-17
CH658455A5 (en) 1986-11-14
KR830009065A (en) 1983-12-17
FI820974L (en) 1982-09-20
ES8404317A1 (en) 1984-05-16
SE8201654L (en) 1982-09-20
ZA821833B (en) 1983-01-26
AU558451B2 (en) 1987-01-29
IE820635L (en) 1982-09-19
IL65247A0 (en) 1982-05-31
IE53076B1 (en) 1988-06-08
NO820903L (en) 1982-09-20
PH18657A (en) 1985-08-29
ES521031A0 (en) 1984-12-01
IN156096B (en) 1985-05-11
GB2095252A (en) 1982-09-29
DE3209708A1 (en) 1982-10-21
BE892552A (en) 1982-09-20
ES510498A0 (en) 1983-08-01
NL8201066A (en) 1982-10-18
ES521030A0 (en) 1984-05-16
IT8220259A0 (en) 1982-03-18
FR2502149B1 (en) 1985-01-18
JPS57165355A (en) 1982-10-12
KR890001146B1 (en) 1989-04-25
FR2502149A1 (en) 1982-09-24

Similar Documents

Publication Publication Date Title
ES8501363A1 (en) N-(substituted aminoalkanoyl)heterocyclic compounds
IE830897L (en) Dihydropyridine derivatives.
HU9401221D0 (en) New heterocyclic compounds
ES8703142A1 (en) Benzimidazole derivatives
FI831009L (en) SPIRO / 4 (3 + N) / - 2-AZA-3-CARBOXYLSYRA DERIVATIVES, FORM OF FIRE
PT82480A (en) Process for the preparation of 2-amino thiazoles n-substituted and for the corresponding pharmaceutical compositions
ES466366A1 (en) Meta-sulfonamido-benzamides
DK291488A (en) ALKANSULPHONANILIDE DERIVATIVES
NZ218244A (en) Phenoxy betacarboline derivatives and pharmaceutical compositions
ES455741A1 (en) Pharmacologically active compounds
DK160184A (en) BIS (PIPERAZINYL OR HOMOPIPERAZINYL) ALKANES AND ACID ADDITION SALTS THEREOF, PROCEDURE FOR THEIR PREPARATION AND THEIR USE
DK32287A (en) 3-ACYLAMINOMETHYL-IMIDAZO (1,2-A) PYRIDINE DERIVATIVES, PROCEDURES FOR PREPARING IT, AND MEDICINAL CONTAINING SUCH DERIVATIVES
ES8404335A1 (en) Alkylene(cycloalkylene)-bis-heterocyclyl biguanide.
MY100760A (en) Fungicides
ES8606325A1 (en) 3-Amino-2,3-dihydro-1-benzoxepine compounds, process for their preparation and medicaments containing these compounds.